A multicultural group practicing yoga together in a bright studio

Direct Meds vs Luvo Health: GLP-1 Comparison 2026

Direct Meds vs Luvo Health: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Verified May 2026.

By RangeYourselfUpdated May 6, 20264 min read

Quick answer

Direct Meds and Luvo Health both offer GLP-1 telehealth, but they package medication, support, and pricing differently. The right choice depends on whether you weight cost, clinical touch, or formulation flexibility highest.

Side-by-side comparison

Feature	Direct Meds	Luvo Health
Best for	Multiple compounded formats (injection and sublingual)	Shoppers who want an openly published, no-intake-required price ladder for peptide/longevity therapy (sermorelin, NAD+) with named dispensing pharmacies
Medication type	Compounded semaglutide and tirzepatide	Compounded peptide and longevity therapies — sermorelin, and NAD+ as injection, sublingual drops or nasal spray — alongside compounded GLP-1, brand-name GLP-1, hormone replacement, testosterone and dermatology lines.
Pricing model	All-inclusive monthly price by medication format	Cash-pay subscription billed per plan TERM of 4, 12, 24 or 52 weeks, with one openly published price per medication per term and no membership or separate consult fee; longer terms cost less per week. Luvo's terms run in WEEKS, not calendar months, so every per-month figure shown here is its 52-week plan total divided by 12.
Semaglutide price	From $249/mo (sublingual) to $297/mo (injection), all-inclusive, verified 2026-07-25 on Direct Meds' own product pages ('$249.00 / month … Billed Every Month', '0% OFF')	$194/mo on the 52-week plan for compounded injection (Luvo's published $2,327 term total divided by 12 calendar months); $249 per 4-week term with no commitment. Verified 2026-08-08.
Tirzepatide price	From $299/mo (sublingual) to $399/mo (injection), all-inclusive, verified 2026-07-25	$291/mo on the 52-week plan for compounded injection (Luvo's published $3,497 term total divided by 12 calendar months); $339 per 4-week term with no commitment. Verified 2026-08-08.
Key watchout	Pricing varies by format and page, product-page 'all-inclusive' rates differ from homepage promo cards; confirm your format's rate at checkout	Every ranked Luvo rate on this site is the 52-week (one-year) plan rate, expressed per calendar month — Luvo itself publishes plan-TERM totals in weeks, not monthly prices, and 52 weeks is 13 four-week cycles rather than 12. Buying without that year-long commitment costs materially more: the no-commitment 4-week term is $199 for sermorelin or NAD+ and $249 for compounded semaglutide. Luvo names four dispensing compounding pharmacies but states no 503A/503B status for any of them, makes no third-party testing or potency claim, and says its own evaluation does not include lab testing. Geographic availability is a qualified all-50-states claim: Luvo's Terms say some services may not be available in all states, and Luvo's affiliate program says a confirmed restricted-state list is still forthcoming from its clinical team.

When to choose Direct Meds

You want a specific format, injection or sublingual, at a clear all-inclusive price
You're already familiar with GLP-1 dosing and side-effect management
You don't need a coach or a heavy-touch clinical team
You want a no-frills, predictable monthly bill

Check current Direct Meds pricing →

When to choose Luvo Health

You want peptide/longevity pricing published openly on the website instead of gated behind an intake form
You want the dispensing pharmacy named before you buy (Luvo lists four in its Terms)
You are comparing sermorelin and the three NAD+ delivery forms at one provider
You are willing to commit to a longer term (24 or 52 weeks) to get the lowest per-week rate

Check current Luvo Health pricing →

Full reviews

Frequently asked questions

Is Direct Meds cheaper than Luvo Health?

Luvo Health starts lower on semaglutide ($194/mo on the 52-week plan for compounded injection (Luvo's published $2,327 term total divided by 12 calendar months); $249 per 4-week term with no commitment. Verified 2026-08-08.). Luvo Health starts lower on tirzepatide ($291/mo on the 52-week plan for compounded injection (Luvo's published $3,497 term total divided by 12 calendar months); $339 per 4-week term with no commitment. Verified 2026-08-08.). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Direct Meds or Luvo Health?

Luvo Health starts lower on both semaglutide and tirzepatide based on listed entry pricing. That said, the right pick is the program whose support model and formulation match what you actually need.

Are Direct Meds and Luvo Health compounded or brand-name?

Direct Meds offers compounded semaglutide and tirzepatide. Luvo Health offers compounded peptide and longevity therapies — sermorelin, and nad+ as injection, sublingual drops or nasal spray — alongside compounded glp-1, brand-name glp-1, hormone replacement, testosterone and dermatology lines.. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Direct Meds to Luvo Health?

Yes, switching between Direct Meds and Luvo Health is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Direct Meds and Luvo Health to other programs

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers as of May 2026 and may change. Numbers like $249/mo (sublingual) to $297/mo (injection), all-inclusive, verified 2026-07-25 on Direct Meds' own product pages ('$249.00 / month … Billed Every Month', '0% OFF') and $194/mo on the 52-week plan for compounded injection (Luvo's published $2,327 term total divided by 12 calendar months); $249 per 4-week term with no commitment. Verified 2026-08-08. are starting tiers, not your guaranteed long-term cost.